BHCFX
Price
$17.67
Change
+$0.13 (+0.74%)
Updated
Jul 25 closing price
Net Assets
141.44M
JFNIX
Price
$67.37
Change
+$0.24 (+0.36%)
Updated
Jul 25 closing price
Net Assets
4.4B
Interact to see
Advertisement

BHCFX vs JFNIX

Header iconBHCFX vs JFNIX Comparison
Open Charts BHCFX vs JFNIXBanner chart's image
Baron Health Care Retail
Price$17.67
Change+$0.13 (+0.74%)
VolumeN/A
Net Assets141.44M
Janus Henderson Global Life Sciences I
Price$67.37
Change+$0.24 (+0.36%)
VolumeN/A
Net Assets4.4B
BHCFX vs JFNIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BHCFX vs. JFNIX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHCFX is a Buy and JFNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.4B vs. BHCFX (141M). JFNIX pays higher dividends than BHCFX: JFNIX (0.41) vs BHCFX (0.22). BHCFX was incepted earlier than JFNIX: BHCFX (7 years) vs JFNIX (16 years). BHCFX (1.18) is less costly to investors than JFNIX (0.77). BHCFX is a more actively managed with annual turnover of: 49.00 vs. JFNIX (35.00). BHCFX has a lower initial minimum investment than JFNIX: BHCFX (2000) vs JFNIX (2500). BHCFX annual gain was more profitable for investors over the last year : -12.66 vs. JFNIX (-14.09). BHCFX return over 5 years is better than : 18.26 vs. JFNIX (5.60).
BHCFXJFNIXBHCFX / JFNIX
Total Expense Ratio1.100.77143%
Annual Report Gross Expense Ratio1.180.77153%
Fund Existence7 years16 years-
Gain YTD-6.951-0.956727%
Front LoadN/AN/A-
Min. Initial Investment2000250080%
Min. Initial Investment IRAN/AN/A-
Net Assets141M4.4B3%
Annual Yield % from dividends0.220.4155%
Returns for 1 year-12.66-14.0990%
Returns for 3 years-0.829.36-9%
Returns for 5 years18.265.60326%
Returns for 10 yearsN/A7.79-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMIDX18.310.19
+1.05%
Brown Advisory Mid-Cap Growth Investor
TRSZX22.830.19
+0.84%
T. Rowe Price Mid-Cap Index Z
MSFLX34.720.19
+0.55%
Morgan Stanley Inst Global Franchise L
JGTTX41.190.20
+0.49%
JPMorgan Growth Advantage R3
LMRNX33.170.10
+0.30%
1919 Socially Responsive Balanced I